AnandRathi

Balaxi Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
22.44
+0.03 (+0.13%)

Balaxi Pharmaceuticals Ltd (Balaxi Pharma) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹124 crore.

Balaxi Pharmaceuticals Ltd Overview

Market cap₹124 Crs
Volume6,825
Prev. Close₹22.41
Year range₹15.20 - ₹47.87
Total Value₹1,53,153.00
ISININE618N01022

Balaxi Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)5.78%
P/E Ratio (TTM)33.49
P/B Ratio0.93
Debt to Equity0.27
ROE3.87%
EPS (TTM)0.67
Dividend Yield0.00%
Book Value24.09
Profit Margin4.64%
Operating Margin-2.45%

Balaxi Pharmaceuticals Ltd Historical Performance

1 Month Return-8.00%
6 Month Return13.74%
3 Year Return-75.55%
3 Month Return-10.13%
1 Year Return-50.85%
5 Year Return-79.09%

Balaxi Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research